US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 0.308
- +0.001+0.16%
Close Nov 25 16:00 ET
- 0.313
- +0.006+1.82%
Post 18:43 ET
4.44MMarket Cap-151P/E (TTM)
0.323High0.276Low1.24MVolume0.285Open0.307Pre Close379.26KTurnover13.92%Turnover RatioLossP/E (Static)14.43MShares13.55852wk High-0.97P/B2.75MFloat Cap0.20752wk Low--Dividend TTM8.95MShs Float13.558Historical High--Div YieldTTM15.31%Amplitude0.207Historical Low0.304Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005
Websitehttps://www.silexion.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Prospective Chief Executive Officer
- 253.61K
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
- 26.24K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 206.80K
- Avner Lushi
- Independent Director
- --
- Ilan Levin
- Independent Director
- --
- Dror J. Abramov
- Independent Director
- --
- Ruth Alon
- Independent Director
- --
- Shlomo Noy
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data